Antibacterial activity of remifentanil and mixtures of remifentanil and propofol

Journal of Clinical Anesthesia

Volumn 19, Issue 5, 2007, Pages 346-350

  Apan, Teoman Zafer ^a   Apan, Alpaslan ^a   Şahin, Şaziye ^a   Çakirca, Mehmet ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Anesthetic; Bacterial growth; Intravenous; Propofol; Remifentanil

Indexed keywords

GLYCINE; PROPOFOL; REMIFENTANIL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CANDIDA ALBICANS; DRUG BLOOD LEVEL; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANESTHETICS, COMBINED; CANDIDA ALBICANS; ESCHERICHIA COLI; GLYCINE; GLYCINE AGENTS; MICROBIAL SENSITIVITY TESTS; PIPERIDINES; PROPOFOL; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 34548513062     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.02.005     Document Type: Article

References (23)

1. Bennet S.N., McNeil M.M., Bland L.A., et al. Postoperative infections traced to contamination of intravenous anesthetic propofol. N Engl J Med 333 (1995) 147-154
2. Henry B., Plante-Jerkins C., and Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 29 (2001) 312-315
3. Kuehnert M.J., Webb R.M., Jochimsen E.M., et al. Staphylococcus aureus bloodstream infection among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol. Anesth Analg 95 (1997) 420-425
4. Weber B., Gachot B., Bedos J.P., and Wolff M. Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology 80 (1994) 712-713
5. Trépainer C., and Lessard M.R. Propofol and the risk of transmission of infection. Can J Anaesth 50 (2003) 533-537
6. Scott L.J., and Penny C.M. Remifentanil: a review of its use during the induction and maintenance of general anaesthesia. Drugs 65 (2005) 1793-1823
7. Sneyd J.R., Andrews C.J.H., and Tsubokawa T. Comparison of propofol/remifentanil and sevoflurane/remifentanil for maintenance of anaesthesia for elective intracranial surgery. Br J Anaesth 94 (2005) 778-783
8. Obayashi A., Oie S., and Kamiya A. Microbial viability in preparations packaged for single use. Biol Pharm Bull 26 (2003) 667-670
9. Sosis M.B., and Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 77 (1993) 766-768
10. Tessler M., Dascal A., Gioseffini S., Miller M., and Mendelson J. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media. Can J Anaesth 39 (1992) 509-511
11. Keammerer D., Mayhall C.G., Hall G.O., Pesco L.J., and Thomas R.B. Microbial growth patterns in fat emulsions. Am J Hosp Pharm 40 (1983) 1650-1653
12. McLeod G.A., Pace N., and Inglis M.D. Bacterial growth in propofol. Br J Anaesth 67 (1991) 665-666
13. Zacher A.N., Zornow M.H., and Evans G. Drug contamination from opening glass ampules. Anesthesiology 75 (1991) 893-895
14. Halkes M.J., and Snow D. Re-use of equipment between patients receiving total intravenous anaesthesia: a postal survey of current practice. Anaesthesia 58 (2003) 582-587
15. Berry C.B., Gillespie T., Hood J., and Scott N.B. Growth of micro-organisms in solutions of intravenous anaesthetic agents. Anaesthesia 48 (1993) 30-32
16. Crowther J., Hrazdil J., Jolly D.T., Galbraith J.C., Greacen M., and Grace M. Growth of microorganisms in propofol, thiopental, and a 1:1 mixtures of propofol and thiopental. Anesth Analg 82 (1996) 475-478
17. Harvey B.R., and Ganzberg S. Growth of microorganisms in propofol and methohexital mixture. J Oral Maxillofac Surg 61 (2003) 818-832
18. Sakuragi T., Yanagisawa K., Shirai Y., and Dan K. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine. Acta Anaesthesiol Scand 43 (1999) 476-479
19. Wachowski I., Jolly D.T., Hrazdil J., Galbraith J.C., Greacen M., and Clanachan A.S. The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesth Analg 88 (1999) 209-212
20. Vidovich M.I., Peterson L.R., and Wong H.Y. The effect of lidocaine on bacterial growth. Anesth Analg 88 (1999) 936-938
21. Gajraj R.J., Hodson M.J., Gillespie J.A., Kenny G.N., and Scott N.B. Antibacterial activity of lidocaine in mixtures with Diprivan. Br J Anaesth 81 (1998) 444-448
22. Ozer Z., Ozturk C., Altunkan A.A., Cinel I., and Oral U. Inhibition of bacterial growth by lidocaine in propofol emulsion. Anaesth Intensive Care 30 (2002) 179-182
23. Wolfson J.S., and Swartz M.N. Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 312 (1985) 968-975